~he range is licensed for the alleviation of inflammation and relief of pain, in both acute and chronic musculoskeletal disorders. Meloxicam is a COX-2 preferential non-steroidal anti-inflammatory drug, associated with fewer negative effects on the gastrointestinal tract than phenylbutazone1,2. In a recent peer-reviewed publication, meloxicam was shown to be more efficacious at reducing pain in horses with acute synovitis than phenylbutazone3. Product Features & Benefits: • COX-2 preferential non-steroidal anti-inflammatory drug • Convenient once daily dosing • No loading dose required • Small volume of granules • Apple flavoured and highly palatable • Part of the Inflacam® range providing flexible dosing options for every horse Presentations Available: Boxes of 100 x 330mg sachets